Prenatal Cell-free DNA Screening is organized by Mayo Foundation for Medical Education and Research and would be held during Jul 24, 2017 - Jul 23, 2020.
The target audience for this medical event for Obstetricians, nurses, and all medical practitioners who work with pregnant women to provide and/or discuss prenatal screening and testing. This CME Conference has been approved with a maximum of 1.0 AMA PRA Category 1 Credits.
Course Description :
Prenatal cell-free DNA screening (or cfDNA screening, often referred to as NIPT or noninvasive prenatal testing) is an increasingly popular and valuable tool for health professionals in obstetrics and gynecology, but proper clinical implementation is complex. In this three-module, hybrid-learning course, you will learn the benefits and limitations of prenatal cfDNA screening, how to interpret test results, and how to communicate with and manage patients who are considering cfDNA testing. This three-module course was developed in collaboration with Mayo Clinic and the American Society of Human Genetics (ASHG).
Conference Objectives are :
• Explain the benefits and limitations of prenatal cfDNA screening
• Describe how to facilitate informed consent about prenatal cfDNA
• Interpret the results of prenatal cfDNA screening tests to appropriately manage patients
• Summarize the practical issues (costs, consent, and lab-specific) related to the use of cfDNA screening in practice